We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
MONTREAL and CHARLOTTE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0688 | 3.45728643216 | 1.99 | 2.23 | 1.94 | 655681 | 2.04036024 | CS |
4 | 0.0701 | 3.52491577412 | 1.9887 | 2.75 | 1.9 | 777700 | 2.1684494 | CS |
12 | 0.6088 | 41.9862068966 | 1.45 | 2.75 | 1.4 | 547929 | 1.98382049 | CS |
26 | 0.5591 | 37.2807894912 | 1.4997 | 2.75 | 1.2691 | 313165 | 1.85463704 | CS |
52 | 0.4888 | 31.1337579618 | 1.57 | 2.75 | 1.12 | 275606 | 1.77863831 | CS |
156 | -4.6712 | -69.4086181278 | 6.73 | 9.8465 | 1.12 | 238531 | 3.73565308 | CS |
260 | -19.2112 | -90.3206393982 | 21.27 | 23.245 | 1.12 | 527408 | 6.07206149 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions